Groww Logo
Home>US Stocks>4D Molecular Therapeutics Inc
4

4D Molecular Therapeutics Inc

Healthcare
$7.64
+ $0.20 (2.69%) 1D
1D
1W
1M
1Y
3Y
5Y

Performance

Today’s Low
$
    Today’s High
    $
    52W Low
    $
      52W High
      $
      Open PricePrev. CloseVolumeAvg. Volume
      $7.43$7.44188,352207,201

      Fundamentals

      Market Cap$246.80M
      P/B Ratio0.8
      P/E Ratio-3
      Enterprise Value$187.60M
      Div. Yield0.00%
      Book Value9.19
      EPS(TTM)-0.82
      ROENA
      Understand Fundamentals

      Company Financials

      *All values are in Million $
      No Graph Data To Display
      Quarterly
      Yearly
      See Details

      FAQs on 4D Molecular Therapeutics Inc

      Can I Buy 4D Molecular Therapeutics Inc Shares in India?

      Yes, 4D Molecular Therapeutics Inc shares can be bought in India by opening an international trading account with Groww.

      How to Buy 4D Molecular Therapeutics Inc Shares in India?

      One can easily invest in 4D Molecular Therapeutics Inc shares from India by: Direct Investment - Opening an international trading account with Groww which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy 4D Molecular Therapeutics Inc shares. Indirect Investment - Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of 4D Molecular Therapeutics Inc.

      What is the Share Price of 4D Molecular Therapeutics Inc?

      The share price of 4D Molecular Therapeutics Inc is in Dollars and if you are investing from India, you can always check the INR valuation before investing. The current 4D Molecular Therapeutics Inc share price is $7.64 as of 27 May ‘22

      What is the Market Cap of 4D Molecular Therapeutics Inc?

      The 4D Molecular Therapeutics Inc market cap is $246.80M as of 27 May ‘22

      What is the PE and PB ratio of 4D Molecular Therapeutics Inc?

      The PE and PB ratio of 4D Molecular Therapeutics Inc is -3 and 0.8 as of 27 May ‘22
      ⓒ 2016-2022 Groww. All rights reserved, Built with in India
      MOST POPULAR ON GROWWVERSION - 2.4.0
      STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
      MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI

      ABOUT GROWW